| Previous close | 101.07 |
| Open | 100.81 |
| Day's range | 100.09 to 101.82 |
| 52-week range | 81.97 to 135.45 |
| Volume | 7.78M |
| Average volume (3 months) | 9.85M |
| 1-year price change | -23.91% |
| Market value | 175.27B |
| P/E ratio (last 12 months) | 28.3 |
| EPS (last 12 months) | 3.58 |
| Beta (1 year) | 0.03 |
| Dividend yield | 3.07% |
Company figures come from SEC filings through the quarter ending Mar 31, 2026. All statistics
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
For learning only, not investment advice. Chart by TradingView. How to read a stock quote.